NT-proBNP levels have been found to be associated with heart failure mortality in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial, which consists of 18,201 patients with AF treated with apixaban or warfarin [7]. The gene discussed is NPPB; the disease is atrial fibrillation.